No categorizado
EU approves merger of Pfizer off-patent unit and Mylan
Brussels, April 22, 2020 (AFP) – The European Commission on Wednesday authorised a merger of US drug giant Pfizer’s off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
